Pacira | PCRX - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Astellas Pharma JPY 1.23T 16.36B 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Cara Therapeutics USD 11.26M 216K 2026-03
Coherus Biosciences USD 75.51M 56.82M 2026-06
Heron Therapeutics USD 92.14M 1.63M 2026-06
Ironwood Pharmaceuticals USD 236.31M 5.91M 2026-03
J&J USD 54.9B 2.82B 2026-06
Ligand Pharmaceuticals USD 46.74M 6.07M 2026-06
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Novo Nordisk DKK 239.08B 13.92B 2026-06
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 122.01M 13.22M 2026-06
Perrigo USD 1.05B 57.2M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Supernus Pharmaceuticals USD 347.38M 26.55M 2026-06
Teva Pharmaceutical Industries USD 15.65B 2.11B 2026-06
Xeris Pharmaceuticals USD 189.57M 70.97M 2026-06
Zoetis USD 2.06B 8M 2026-06